prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37  |review
The essential components of any CVD control program would be the following: (1) establishment of efficient systems for estimation of CVD-related burden of disease and its secular trends; (2) estimation of the levels of established CVD risk factors (eg, smoking, elevated cholesterol, or blood pressure) in representative population samples to help identify risk factors that require immediate intervention; (3) evaluation of emerging risk factors (eg, glucose, abdominal obesity, fibrinolytic status, homocysteine) that may be of special relevance to the populations concerned; (4) identification of the determinants of health behavior that influence the levels of both traditional and emerging risk factors in the specific context of each society; and (5) development of a health policy that will integrate population-based measures for CVD risk modification and cost-effective case management strategies for individuals who have clinically manifested CVD or are detected to be at a high risk of developing it.